Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02564536
Title Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

juvenile myelomonocytic leukemia

myelofibrosis

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

Therapies

Decitabine + Pacritinib

Age Groups: adult
Covered Countries


No variant requirements are available.